300347 Hangzhou Tigermed Consulting Co., Ltd. SZSE · China

Hangzhou Tigermed Consulting Co. (300347) news

Hangzhou Tigermed Consulting Co., Ltd. is a public biotech or pharmaceutical company listed on SZSE under the ticker 300347, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Hangzhou Tigermed Consulting Co. news

We have not published a story on Hangzhou Tigermed Consulting Co. yet. When there is news, it will appear here.

Questions about Hangzhou Tigermed Consulting Co.

What is the ticker symbol of Hangzhou Tigermed Consulting Co.?

Hangzhou Tigermed Consulting Co., Ltd. trades under the ticker 300347 on SZSE.

Where is Hangzhou Tigermed Consulting Co. listed?

Hangzhou Tigermed Consulting Co., Ltd. is listed on SZSE. Our directory also records these other listings: GETTEX:5HZ1; HKEX:3347.

Which country or territory is Hangzhou Tigermed Consulting Co. listed under?

Our directory records Hangzhou Tigermed Consulting Co., Ltd. under China.

What does Hangzhou Tigermed Consulting Co. do?

Our directory classifies Hangzhou Tigermed Consulting Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Hangzhou Tigermed Consulting Co.?

The ISIN recorded for Hangzhou Tigermed Consulting Co., Ltd. is CNE100001KV8.

Does aibio.space cover Hangzhou Tigermed Consulting Co.?

aibio.space lists Hangzhou Tigermed Consulting Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Hangzhou Tigermed Consulting Co.?

Companies in our directory listed in the same country and business area as Hangzhou Tigermed Consulting Co.: Medtide, Alebund Pharmaceuticals (Jiangsu), Alphamab Oncology, Bon Natural Life, Hanx Biopharmaceuticals (Wuhan) Co., Zhejiang Hengtong Holding Co..

Investor discussion: Hangzhou Tigermed Consulting Co.

Members talk about Hangzhou Tigermed Consulting Co. (300347). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SZSE:300347 on TradingView.

Listing details

Company: Hangzhou Tigermed Consulting Co., Ltd.
Ticker: 300347
Listing: SZSE
Country or territory: China
Business scope: Biotechnology
ISIN: CNE100001KV8
Other listed symbols: GETTEX:5HZ1; HKEX:3347
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction